Reply to: Inconsistencies in 2022 ISPD peritonitis guidelines

Perit Dial Int. 2023 May;43(3):276-278. doi: 10.1177/08968608231170782.

Kai Ming Chow^{1

2}, Naomi Runnegar³, Simon Wai-Yin So⁴, Yeoungjee Cho^{5

6}, David W Johnson^{5

6}, Philip Kam-Tao Li^{1

2}

¹ Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
² CUHK Carol & Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
³ Infectious Management Services, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia.
⁴ Department of Pharmacy, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong.
⁵ Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
⁶ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.

No abstract available

Publication types